2018 American Transplant Congress
Single-Center Experience of Biliary Reconstruction for Multiple Bile Duct in Right Lobe Living Donor Liver Transplantation
Department of Surgery, Catholic University of Daegu College of Medicine, Daegu, Korea.
Biliary anastomosis stricture (BAS) is still major concerns especially for living donor liver transplantation (LDLT). Recent studies have described multiple duct and multiple anastomoses as…2018 American Transplant Congress
Sequential Percutaneous Insertion of Two Plastic Biliary Stents through One Percutaneous Access for Biliary Anastomotic Strictures after Liver Transplantation
Introduction: Our purpose was to evaluate the management of biliary anastomotic strictures with simultaneous multiple percutaneous plastic stents for liver transplantsMaterials and Methods: Between 2007…2018 American Transplant Congress
Two Years of the HOPE Act
1United Network for Organ Sharing, Richmond, VA; 2Johns Hopkins University, Baltimore, MD.
The HOPE Act allows research on transplantation of organs from HIV+ donors into patients infected with HIV prior to transplantation. There are 42 kidney and…2018 American Transplant Congress
Race, Income, and Insurance Status Predict Migration for Liver Transplantation in the United States
Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA.
Background: Ongoing organ shortage and regional differences in organ availability have encouraged patients in need of liver transplantation (LT) to travel in order to increase…2018 American Transplant Congress
Impact of Direct Acting Antivirals of Hepatitis C Virus Therapy on Tacrolimus Dosing Post-Liver Transplant
Michigan Medicine, Ann Arbor, MI.
Background: Direct acting antivirals (DAA) have transformed hepatitis C virus (HCV) management post-liver transplant (LT). As HCV clears, hepatic metabolism improves, resulting in decreased tacrolimus…2018 American Transplant Congress
Demographic and Geographic Differences in the Proportion of Liver Disease Deaths Captured by the Transplant Waitlist in the United States, 2011 – 2015
Background: There are no population-based estimates of the prevalence of end-stage liver disease in the United States, creating challenges in measuring disease burden to inform…2018 American Transplant Congress
HLA-DR4 Matching and Hepatocellular Carcinoma Recurrence after Liver Transplantation
PURPOSE: The phenomenon of graft versus host disease after orthotopic liver transplantation (OLT) is estimated at approximately 1-2%, suggesting that under some circumstances, the graft…2018 American Transplant Congress
Hyaluronic Acid as Early Biomarker of Graft Loss after Liver Transplantation: A Prospective Study
Introduction: Improved diagnosis and understanding the pathophysiology of early allograft dysfunction is essential to improve the short-term outcome after liver transplantation (LT). Hyaluronic acid (HA)…2018 American Transplant Congress
Evaluation the Outcomes of Liver Transplant Recipients Underwent Splenectomy: A Meta-Analysis
Organ Transplant Center, Sun yat-sen University, Guangzhou, China.
Background. Splenectomy is performed as strategy of modulating the portal vein pressure in most of portal hypertension patients with liver cirrhosis. In liver transplantation, researchers…2018 American Transplant Congress
DCD Utilization in Cholestatic Liver Disease: Distinct Outcomes between PSC and PBC Recipients
Abdominal Transplant Surgery, Oregon Health & Science University, Portland, OR.
Background: Concern for inferior outcomes in patients with primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) have limited utilization of donation after cardiac death…
- « Previous Page
- 1
- …
- 109
- 110
- 111
- 112
- 113
- …
- 180
- Next Page »